Cargando…
Pathogen-associated gene discovery workflows for novel antivirulence therapeutic development
Novel therapeutics to manage bacterial infections are urgently needed as the impact and prevalence of antimicrobial resistance (AMR) grows. Antivirulence therapeutics are an alternative approach to antibiotics that aim to attenuate virulence rather than target bacterial essential functions, while mi...
Autores principales: | Lau, Wing Yin Venus, Taylor, Patrick K., Brinkman, Fiona S.L., Lee, Amy H.Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843249/ https://www.ncbi.nlm.nih.gov/pubmed/36628845 http://dx.doi.org/10.1016/j.ebiom.2022.104429 |
Ejemplares similares
-
The arsenal of pathogens and antivirulence therapeutic strategies for disarming them
por: Brannon, John R, et al.
Publicado: (2016) -
Antivirulence and avirulence genes in human pathogenic fungi
por: Siscar-Lewin, Sofía, et al.
Publicado: (2019) -
Quorum Sensing as Antivirulence Target in Cystic Fibrosis Pathogens
por: Scoffone, Viola Camilla, et al.
Publicado: (2019) -
Uncharted territories in the discovery of antifungal and antivirulence natural products from bacteria
por: Vij, Raghav, et al.
Publicado: (2021) -
Microbial Genomics as a Catalyst for Targeted Antivirulence Therapeutics
por: Sintchenko, Vitali, et al.
Publicado: (2021)